A team of researchers including a member of the Quantum Science Center at ORNL has published a review paper on the state of the field of Majorana research. The paper primarily describes four major platforms that are capable of hosting these particles, as well as the progress made over the past decade in this area.
ORNL scientists are working on a project to engineer and develop a cryogenic ion trap apparatus to simulate quantum spin liquids, a key research area in materials science and neutron scattering studies.
Scientists at Oak Ridge National Laboratory and six other Department of Energy national laboratories have developed a United States-based perspective for achieving net-zero carbon emissions.
The U.S. Environmental Protection Agency has approved the registration and use of a renewable gasoline blendstock developed by Vertimass LLC and ORNL that can significantly reduce the emissions profile of vehicles when added to conventional fuels.
Researchers simulated a key quantum state at one of the largest scales reported, with support from the Quantum Computing User Program, or QCUP, at ORNL.
ORNL’s Erin Webb is co-leading a new Circular Bioeconomy Systems Convergent Research Initiative focused on advancing production and use of renewable carbon from Tennessee to meet societal needs.
Chuck Greenfield, former assistant director of the DIII-D National Fusion Program at General Atomics, has joined ORNL as ITER R&D Lead.
ORNL and the University of Tennessee, Knoxville, co-hosted the 2023 National Society of Black Physicists Annual Conference with the theme "Frontiers in Physics: From Quantum to Materials to the Cosmos.” As part of the three-day conference held near UT, attendees took a 30-mile trip to the ORNL campus for facility tours, science talks and workshops.
From July 15 to 26, 2024, the Department of Energy’s Oak Ridge National Laboratory will host the second U.S. Quantum Information Science, or QIS, Summer School.
New computational framework speeds discovery of fungal metabolites, key to plant health and used in drug therapies and for other uses.